XML 53 R43.htm IDEA: XBRL DOCUMENT
v3.22.4

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Dec. 31, 2022 USD ($) segment | Jan. 01, 2022 USD ($)
Segment Reporting Information [Line Items] |  |  |  |
Number of reportable segments | segment |  |  | 3 |
Net revenues before foreign exchange impact | $ 307,290 | $ 253,319 | $ 863,191 | $ 707,630
Effect of exchange rates | (7,361) | 1,014 | (14,865) | 4,909
Net revenues | 305,301 | 259,769 | 864,244 | 728,194
Operating (loss) income | 43,279 | 35,651 | 120,778 | 61,551
Effect of exchange rates | 3,581 | 5,807 | 9,775 | 15,553
Amortization | 8,078 | 12,151 | 24,666 | 35,930
Restructuring and turnaround costs | (4,123) | (5,682) | (10,795) | (20,250)
Impairment of assets and PCS2 related charges | 1 | (897) | 268 | (4,790)
Integration and transaction costs | (287) | (1,860) | 425 | (19,218)
MDR and IVDR costs | (2,483) | (2,453) | (8,175) | (7,171)
Litigation-related charges | (757) | (138) | (1,151) | (1,221)
Gain on sale of assets | 0 | 0 | 382 | 9,603
United States |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 224,104 | 167,270 | 617,824 | 460,404
Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 15,552 | 19,916 | 44,559 | 55,949
Europe |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 39,105 | 41,540 | 121,412 | 126,055
Asia |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 25,454 | 30,434 | 77,739 | 83,157
Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 1,086 | 609 | 2,710 | 2,629
Service |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 5,372 | 5,436 | 15,918 | 15,655
Plasma products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 153,899 | 116,347 | 415,412 | 308,931
Blood Center products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 58,273 | 59,440 | 173,086 | 177,118
Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 93,129 | 83,982 | 275,746 | 242,145
Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 136,574 | 96,692 | 368,504 | 250,499
Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 76,827 | 74,527 | 219,052 | 221,522
Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 93,889 | 82,100 | 275,635 | 235,609
Operating Segments |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 148,927 | 121,038 | 416,570 | 329,905
Operating Segments | Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 76,365 | 51,405 | 203,098 | 128,964
Operating Segments | Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 35,005 | 34,561 | 102,710 | 103,043
Operating Segments | Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 37,557 | 35,072 | 110,762 | 97,898
Corporate |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | $ 93,502 | $ 68,013 | $ 261,855 | $ 204,930

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition European Medical Device Regulation Costs + References No definition available. + Details
Name: | hae_EuropeanMedicalDeviceRegulationCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impairment Of Assets And PCS2 Related Charges (Credits) + References No definition available. + Details
Name: | hae_ImpairmentOfAssetsAndPCS2RelatedChargesCredits
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net Revenues, By Business Unit Before Foreign Exchange Impact + References No definition available. + Details
Name: | hae_NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating Expenses, Transaction Costs + References No definition available. + Details
Name: | hae_OperatingExpensesTransactionCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Restructuring and Turnaround Costs + References No definition available. + Details
Name: | hae_RestructuringandTurnaroundCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnDispositionOfAssets1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599 + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |